BindingDB Data by Journal
PMID
Data
Article Title
Citation
Organization
Download Data
Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies.
RSC Med Chem 15: 10-54 (2024)
Csir-Central Glass & Ceramic Research Institute
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery.
RSC Med Chem 15: 70-80 (2024)
Shandong University
Physicochemical characterization of
RSC Med Chem 15: 119-126 (2024)
Tokyo Medical and Dental University
Discovery of imidazo[1,2-
RSC Med Chem 15: 178-192 (2024)
Purdue University
Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease.
RSC Med Chem 15: 193-206 (2024)
Guangzhou Medical University
Highly efficient, catalyst-free, one-pot sequential four-component synthesis of novel spiroindolinone-pyrazole scaffolds as anti-Alzheimer agents:
RSC Med Chem 15: 207-222 (2024)
Persian Gulf University
The development of thymol-isatin hybrids as broad-spectrum antibacterial agents with potent anti-MRSA activity.
RSC Med Chem 15: 234-253 (2024)
Guru Nanak Dev University
A survey of stapling methods to increase affinity, activity, and stability of ghrelin analogues.
RSC Med Chem 15: 254-266 (2024)
University of Western Ontario
Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents:
RSC Med Chem 15: 293-308 (2024)
Misr International University
Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.
RSC Med Chem 15: 309-321 (2024)
Punjabi University
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats.
RSC Med Chem 15: 344-354 (2024)
Idorsia Pharmaceuticals
Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules.
RSC Med Chem 15: 399-415 (2024)
University of Arkansas
Role of heterocycles in inhibition of VEGFR-2 - a recent update (2019-2022).
RSC Med Chem 15: 416-432 (2024)
Srmpp
Discovery of dual-action phenolic 4-arylidene-isoquinolinones with antioxidant and α-glucosidase inhibition activities.
RSC Med Chem 15: 519-538 (2024)
National Autonomous University of Mexico
Discovery of 5-trifluoromethyl-2-aminopyrimidine derivatives as potent dual inhibitors of FLT3 and CHK1.
RSC Med Chem 15: 539-552 (2024)
Zhejiang University
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators.
RSC Med Chem 15: 607-611 (2024)
Dana-Farber Cancer Institute
Small molecule WDR5 inhibitors down-regulate lncRNA expression.
RSC Med Chem 15: 636-640 (2024)
Max Planck Institute of Molecular Physiology
Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents.
RSC Med Chem 15: 704-719 (2024)
Korea Research Institute of Chemical Technology
Consensus screening for a challenging target: the quest for P-glycoprotein inhibitors.
RSC Med Chem 15: 720-732 (2024)
The Scripps Research Institute
Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors.
RSC Med Chem 15: 733-752 (2024)
Health Affairs Directorate - Giza
Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies.
RSC Med Chem 15: 788-808 (2024)
Tianjin University
The medicinal chemistry evolution of antibody-drug conjugates.
RSC Med Chem 15: 809-831 (2024)
Abbvi
-Arylsulfonamide-based adenosine analogues to target RNA cap
RSC Med Chem 15: 839-847 (2024)
University of Montpellier Cnrs
Discovery of benzoheterocyclic-substituted amide derivatives as apoptosis signal-regulating kinase 1 (ASK1) inhibitors.
RSC Med Chem 15: 856-873 (2024)
South China University
Inhibition of N-type calcium channels by phenoxyaniline and sulfonamide analogues.
RSC Med Chem 15: 916-936 (2024)
Monash University
Molecular editing of
RSC Med Chem 15: 937-962 (2024)
National Institute of Pharmaceutical Education and Research (NIPER)
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases.
RSC Med Chem 15: 963-980 (2024)
University of Rouen Normandy
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy.
RSC Med Chem 15: 981-997 (2024)
Ain-Shams University
Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.
RSC Med Chem 15: 998-1002 (2024)
Ghent University
Deconvoluting low yield from weak potency in direct-to-biology workflows with machine learning.
RSC Med Chem 15: 1015-1021 (2024)
University of Cambridge
Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of
RSC Med Chem 15: 1022-1037 (2024)
Jamia Millia Islamia (A Central University)
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex.
RSC Med Chem 15: 1066-1071 (2024)
University of Toronto
Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1.
RSC Med Chem 15: 1096-1108 (2024)
China Pharmaceutical University
Small molecules modulating RNA splicing: a review of targets and future perspectives.
RSC Med Chem 15: 1109-1126 (2024)
University of Bordeaux
Progress in small-molecule inhibitors targeting PD-L1.
RSC Med Chem 15: 1161-1175 (2024)
Henan University
1,5-Disubstituted tetrazoles as PD-1/PD-L1 antagonists.
RSC Med Chem 15: 1210-1215 (2024)
University of Groningen
A novel BODIPY-based theranostic agent for
RSC Med Chem 15: 1216-1224 (2024)
Shanghai Institute of Materia Medica
Screening of efficient salicylaldoxime reactivators for DFP and paraoxon-inhibited acetylcholinesterase.
RSC Med Chem 15: 1225-1235 (2024)
Air Force Medical University
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity.
RSC Med Chem 15: 1247-1257 (2024)
University of Florence
Enhanced inhibitory activity of compounds containing purine scaffolds compared to protein kinase CK2α considering crystalline water.
RSC Med Chem 15: 1274-1282 (2024)
Kindai University
Design, synthesis,
RSC Med Chem 15: 1329-1347 (2024)
Central University of Punjab